LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
8.45
-0.17 (-1.95%)
Apr 24, 2026, 9:50 AM EDT - Market open
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $79.39 million as of April 24, 2026. Its market cap has increased by 754.37% in one year.
Market Cap
79.39M
Enterprise Value
-6.56M
1-Year Change
754.37%
Ranking
Category
Stock Price
$8.45
Market Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $79.39M, a decrease of -84.94%. That is a compound annual growth rate of -28.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 80.97M | 171.22% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 89.88M |
| Adicet Bio | 89.33M |
| eXoZymes | 89.03M |
| Gain Therapeutics | 86.17M |
| Alterity Therapeutics | 85.67M |
| OKYO Pharma | 85.02M |
| NeurAxis | 84.02M |
| Champions Oncology | 83.46M |